Why have reinsurers' facultative underwriters wait until an insurer has finished its process? Why not consult as experts across an ecosystem?
Dr. Dave Rengachary is senior vice president and head of underwriting for U.S. Mortality Markets at RGA Reinsurance Company, where he has served instrumental roles in setting the risk philosophy for the department, oversight of U.S. Manual development, leadership roles across numerous USMM underwriting initiatives and regulatory engagements. He previously served as chief medical director for RGA.
Prior to joining RGA in 2013, Dr. Rengachary was a general neurologist in practice at Missouri Baptist Medical Center, where he also served as medical director for their Primary Stroke Center. He attended the honors program in medical education at Northwestern University. He then completed an adult neurology residency at Washington University followed by a fellowship in clinical neurophysiology. He serves on the board of directors of Memory Home Care Solutions and Oasis, non-profit organizations respectively dedicated to Alzheimer's caregiver support and healthy aging. He has obtained board certification in neurology, insurance medicine, FALU and FLMI. Dr. Rengachary recently received his executive M.B.A. through the program at the Olin Business School at Washington University.
In 2021, Dr. Rengachary accepted a position as chair of ACLI's Risk Classification Committee. He is past-president of the Midwestern Medical Directors Association; current deputy director of the Longer Life Foundation; medical consultant for the Academy of Life Underwriting; and a member of the educational committee of the American Academy of Insurance Medicine.